A £3.8 million investment will create over 150 new jobs at a West Lothian site.
The US multinational Q2 Solutions already employ 250 people in Livingston but the project will create another 156 vacancies over three years.
The new scheme sits alongside an ongoing £17m infrastructure expansion project at the Livingston central laboratories.
The £3.8 million development of the new centre of excellence, supported a Scottish Enterprise grant, will enable the life science company to offer an increased range of services to leading pharmaceutical companies.
Economy secretary Kate Forbes said: “This is excellent news for a business which has received Scottish Government support. Q2 Solutions already has a significant presence in Livingston and this important project will create more high quality jobs and further underlines Scotland’s position as a global player in precision medicine.
“The Scottish Government has worked closely with the company and continues to support the sector following our significant investment in major clinical and research assets such as the Precision Medicines Scotland Innovation Centre.
“Inward investment has a huge role to play in Scotland’s economic transformation. Our skilled workforce, research facilities and supportive investment culture are highly attractive to foreign companies. The Scottish Government is building on that success with an inward investment strategy which focuses on sectors that can deliver high-quality jobs and future growth, including health innovation.”
Elaine Lowey, Q2 Solutions’ general manager for Europe, the Middle East and Africa, said: “I am delighted to lead such a momentous undertaking.
“Expanding our European operations in key technical areas supporting the development of new precision medications adds significant value to our global pharmaceutical and biotechnology clients. We are delighted to be working with Scottish Enterprise in this venture and look forward to the job creation this will bring in our new state-of-the-art facility.”
Scottish Enterprise director of global investment Mark Hallan said: “The company’s proposals for Scotland are incredibly exciting and exactly the type of project Scottish Enterprise aims to support as we look towards economic recovery.
“Scotland has one of the largest life sciences clusters in Europe, with a number of global companies already benefiting from the quality of our workforce. Q2 Solutions’ decision to locate this global centre of excellence at its Livingston site will only bolster our international reputation in this sector. Scottish Enterprise is delighted to have secured this opportunity for Scotland.”
Q2 Solutions are a leading clinical trial laboratory services organization with sites across the world and say they “solve problems that couldn’t have been attempted before.”
All of Q2 Solutions’ European laboratory services are operated from Livingston, including their state of the art laboratory facility, clinical trials materials and logistics departments, specimen handlers, quality assurance and a component of their Project Services team.
Don't miss the latest news from the West Lothian Courier. Sign up to our free newsletter here https://www.dailyrecord.co.uk/newsletter-preference-centre/
